VRTX Market Cap & Key Metrics
Vertex Pharmaceuticals Incorporated
$498.50
+$13.28(+2.74%)
51
Overall
60
Value
30
Tech
63
Quality
Market Cap
$122.98B
Volume
2.06M
52W Range
$402.58 - $560.25
Target Price
$572.86
VRTX market cap is $122.98B. This page lists Vertex Pharmaceuticals Incorporated's P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
VRTX Key Metrics
- Market cap
- $122.98B
- P/E ratio (current-year EPS estimate)
- 29.94
- EPS estimate, current year
- $16.65
- EPS growth, 3-year
- +6.03%
- Value score
- 60
- Quality score
- 63
- Technical score
- 30
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $12.00B | $11.02B | $9.87B | $8.93B | $7.57B |
| EBITDA | $4.87B | $486.30M | $4.61B | $4.44B | $2.92B |
| EPS | $15.46 | $-2.08 | $14.05 | $12.97 | $9.09 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRTX | $498.50 | +2.7% | 2.06M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vertex Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW